Tatiana S. Ermakova

Tatiana S. Ermakova

Auto-generated profile, based on publicly available information

Tatiana S. Ermakova

City clinical oncological dispensary

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2020 in Parodontologiya
Verified
Journal Article
Closed access
PDF file
SKS. I. Kutukova
S. I. Kutukova
ACA. B. Chukhlovin
A. B. Chukhlovin
AYA. I. Yaremenko
A. I. Yaremenko
YIY. V. Ivaskova
Y. V. Ivaskova
ARAlexandra Razumova
Alexandra Razumova
TET. S. Ermakova
T. S. Ermakova
Встречаемость ДНК основных типов онкогенных вирусов в структуре плоскоклеточного рака и нормальной слизистой оболочки полости рта

8 October 2025 in Russian Journal of Oncology
Verified
Journal Article
Closed access
PDF file
TETatiana S. Ermakova
Tatiana S. Ermakova
ETEldar E. Topuzov
Eldar E. Topuzov
VEVladimir A. Ershov
Vladimir A. Ershov
SKSvetlana I. Kutukova
Svetlana I. Kutukova
BACKGROUND: Basal cell carcinoma (BCC) is the most common malignant neoplasm in humans. The cause of local recurrence after radical treatment remains unknown. AIM: The work aimed to identify prognostically significant factors for the development of recurrent basal cell carcinoma of the skin. METHODS: Study involved 100 patients. We analyzed clinicopathological data from 100 cases of BCC, including 50 cases of newly diagnosed basal cell carcinoma of the scalp and 50 cases with recurrent disease. The recurrence of basal cell carcinoma of the scalp and a primary skin tumor were investigated by histological examination. For this work we used the material obtained after treatment of patients. RESULTS: The incidence of BCC recurrence on the nose was four times higher compared to other localizations. Recurrence on the nasal skin occurred in 21 cases; in 29 patients, recurrence was observed when BCC was localized on the skin of the scalp (n = 3), auricle (n = 3), frontal (n = 4), periorbital (n = 8), temporal (n = 2), buccal (n = 7), zygomatic (n = 1), and lip areas (n = 1). Recurrence of BCC in the frontal area was detected 24 months after treatment; with a tumor infiltration depth of 15.1–20 mm, recurrence occurred at 36 months; in the multicentric variant of BCC, recurrence was noted at 24 months postoperatively. CONCLUSION: Diagnostic criteria for BCC recurrence may include localization on the nasal skin, multicentric BCC, BCC originating from skin adnexa, and an infiltration depth of 15.1–20 mm.

28 January 2026 in Clinical Case in Oncology
Verified
Journal Article
Closed access
IGIvan A. Gerk
Ivan A. Gerk
RORashida V. Orlova
Rashida V. Orlova
IIIlya M. Itkin
Ilya M. Itkin
VPVladimir Yu. Pogrebnyakov
Vladimir Yu. Pogrebnyakov
MKMikhail I. Khrustalev
Mikhail I. Khrustalev
TETatyana S. Ermakova
Tatyana S. Ermakova
Sarcomatoid carcinoma of the skin is a rare and aggressive variant of cutaneous squamous cell carcinoma characterized by poor differentiation. Due to the limited number of reported cases, there are no standardized approaches to management, making individual case reports particularly valuable. We describe a young patient presenting with a rapidly enlarging giant sarcomatoid carcinoma of the postauricular region with ulceration and bleeding. A combinedmodality treatment, including surgery and chemoimmunotherapy, resulted in complete clinical and radiological disease control, with no evidence of recurrence at follow-up.